Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

SELLAS Life Sciences Group Inc. (RSLS)

3   0 (0%) 07-09 15:52
Open: 3.5 Pre. Close: 3
High: 3 Low: 3
Volume: 24 Market Cap: 16M
ReShape Lifesciences Inc., a medical device company, focuses on the design, development, and commercialization of technology to treat obesity and metabolic diseases. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in morbidly obese patients without permanently cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was founded in 2002 and is headquartered in San Clemente, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.071 - 3.092 3.092 - 3.109
Low: 2.872 - 2.891 2.891 - 2.907
Close: 2.941 - 2.973 2.973 - 3

Technical analysis

as of: 2020-07-10 4:32:13 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 4.05     One year: 4.59
Support: Support1: 2.71    Support2: 2.25
Resistance: Resistance1: 3.46    Resistance2: 3.93
Pivot: 3.09
Moving Average: MA(5): 3.00     MA(20): 3.08
MA(100): 2.52     MA(250): 4.35
MACD: MACD(12,26): -0.04     Signal(9): -0.02
Stochastic oscillator: %K(14,3): 40.00     %D(3): 38.52
RSI: RSI(14): 46.65
52-week: High: 12.50  Low: 1.46  Change(%): -54.3
Average Vol(K): 3-Month: 20682  10-Days: 19859

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
SLS has closed above bottom band by 36.2%. Bollinger Bands are 0.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 08 Jul 2020
Asbury Automotive Group Inc - Consensus Indicates Potential 3.1% Upside - DirectorsTalk Interviews

Tue, 30 Jun 2020
Jacobs Engineering Group Inc. - Consensus Indicates Potential 21.3% Upside - DirectorsTalk Interviews

Mon, 29 Jun 2020
American Financial Group - Consensus Indicates Potential 19.5% Upside - DirectorsTalk Interviews

Sun, 28 Jun 2020
Citigroup - Consensus Indicates Potential 23.8% Upside - DirectorsTalk Interviews

Mon, 22 Jun 2020
Edwards Lifesciences Corporatio - Consensus Indicates Potential 16.7% Upside - DirectorsTalk Interviews

Sat, 13 Jun 2020
Natural Gas Services Group, Inc - Consensus Indicates Potential 71.4% Upside - DirectorsTalk Interviews

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 7
Shares Float (M) 6
% Held by Insiders 2.08
% Held by Institutions 14.53
Shares Short (K) 189
Shares Short P. Month (K) 263

Stock Financials

EPS -6.731
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 1.200
Profit Margin
Operating Margin
Return on Assets (ttm) -66.2
Return on Equity (ttm) -343.2
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -19
Levered Free Cash Flow (M) -13

Stock Valuations

PE Ratio -0.44
PEG Ratio
Price to Book value 2.47
Price to Sales
Price to Cash Flow -1.02

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.